In the largest Nordic study to date concerning oesophageal cancer surgery, the researchers found clear evidence that ...

Though Glasgow is the first city to trial the idea, there have been questions of how realistic a similar scheme in London ...

Although I'm unable to embed the video here due to the artist's request, it is available for viewing on both You Tube and the ...

An objective response rate of 50.5% was observed with raludotatug deruxtecan across all dose levels in these patients in the phase 2 part of REJOICE-Ovarian01 Phase 3 part of REJOICE-Ovarian01 to ...

Results from the phase 2 (dose optimization) part of the REJOICE-Ovarian01 phase 2/3 trial showed that raludotatug deruxtecan (R-DXd) demonstrated clinically meaningful response rates in patients with ...

CHICAGO — Hospital volume affected the length of stay for patients with COPD who elect to have endobronchial valve placement, with some association with costs as well, according to an abstract ...

FDA Approval to Advance Final FemBloc® Trial with Clear Pathway to Potentially Achieve U.S. FDA Approval - - $12 Million Financing Strengthens Balance Sheet and Extends Cash Runway - ATLANTA, Nov.

Results from the phase 2 (dose optimization) part of the REJOICE-Ovarian01 phase 2/3 trial showed that raludotatug deruxtecan (R-DXd) demonstrated clinically meaningful response rates in patients with ...